Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.

OncoHost has won a €2.5m ($2.8m) grant to develop a novel biomarker capable of predicting cancer patient responses to immunotherapy.

Terumo Neuro (formerly MicroVention) has launched the SOFIA 88 Neurovascular Support Catheter commercially in the US.

New research has revealed that UK adults feel "let down" by mental health services provided by the UK's National Health ...

A new report by Royal Philips warns that the ‘trust gap’ around deploying artificial intelligence (AI) in healthcare systems ...

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

Health Canada has granted approval to Subtle Medical’s magnetic resonance imaging (MRI) enhancement software, SubtleHD.

Bruker and 10x have resolved their patent disputes, dismissed multiple litigations, and established global patent ...

The German multinational joins the long list of companies boosting US manufacturing to counter Trump’s tariffs.

Imperative Care has completed subject enrolment in the pivotal IDE trial, SYMPHONY-PE, to treat acute pulmonary embolism.